Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Analgesic potential of new analogues of valproic acid

Jan. 11, 2006

Preclinical antidementia profile of FK-962

Jan. 11, 2006

Gabapentin GR shows sustained pain relief without sedation

Jan. 10, 2006

Synergistic antidepressant effects seen with M-100907 and fluoxetine

Jan. 9, 2006

Phase II trial investigates iPlex for myotonic muscular dystrophy

Jan. 9, 2006

Novel agents with potential in the treatment of anxiety, depression, etc. revealed in recent patents

Jan. 9, 2006

Orphan drug designation for CellCept in myasthenia gravis

Jan. 9, 2006

Sativex cleared for U.S. phase III trials

Jan. 9, 2006

Amarin licenses LAX-202 rights for MS fatigue to Multicell Technologies

Jan. 5, 2006

Closing of Pain Therapeutics and King's strategic alliance

Jan. 5, 2006

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...